Efficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Adil, Maroof M ^a   Rodrigues, Gonçalo M C ^a   Kulkarni, Rishikesh U ^a   Rao, Antara T ^a   Chernavsky, Nicole E ^a   Miller, Evan W ^a   Schaffer, David V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID RESIN; BIOLOGICAL MARKER; BIOMATERIAL; MACROGOL; POLY-N-ISOPROPYLACRYLAMIDE;

ANIMAL; CELL COUNT; CELL CULTURE TECHNIQUE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; ELECTROPHYSIOLOGY; EXPERIMENTAL IMPLANT; FEMALE; FISCHER 344 RAT; HUMAN; HUMAN EMBRYONIC STEM CELL; INDUCED PLURIPOTENT STEM CELL; MESENCEPHALON; METABOLISM; PROCEDURES; SYNAPSE;

ACRYLIC RESINS; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMARKERS; CELL COUNT; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DOPAMINERGIC NEURONS; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; HUMAN EMBRYONIC STEM CELLS; HUMANS; IMPLANTS, EXPERIMENTAL; INDUCED PLURIPOTENT STEM CELLS; MESENCEPHALON; POLYETHYLENE GLYCOLS; RATS, INBRED F344; SYNAPSES;

EID: 85009444396     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40573     Document Type: Article

References (53)

1. Kriks, S. , et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551 (2011).
2. Grealish, S. , et al. Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's Disease. Cell Stem Cell 15, 653-665 (2014).
3. Doi, D. , et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports 2, 337-350 (2014).
4. Kirkeby, A. , et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 1, 703-714 (2012).
5. Lindvall, O. Dopaminergic neurons for Parkinson's therapy. Nat. Biotechnol. 30, 56-8 (2012).
6. Lee, C.-T. , et al. Functional Consequences of 17q21. 31/WNT3-WNT9B Amplification in hPSCs with Respect to Neural Differentiation. Cell Rep. 10, 616-632 (2015).
7. Swistowski, A. , et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28, 1893-1904 (2010).
8. McNeish, J. , et al. High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors. J. Biol. Chem. 285, 17209-17 (2010).
9. Pouton, C. W., Haynes, J. M. Embryonic stem cells as a source of models for drug discovery. Nat. Rev. Drug Discov. 6, 605-16 (2007).
10. Kim, J., Sachdev, P., Sidhu, K. Alginate microcapsule as a 3D platform for the efficient differentiation of human embryonic stem cells to dopamine neurons. Stem Cell Res. 11, 978-989 (2013).
11. Serra, M., Brito, C., Correia, C., Alves, P. M. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 30, 350-9 (2012).
12. Chen, A. K.-L., Chen, X., Choo, A. B. H., Reuveny, S., Oh, S. K. W. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. 7, 97-111 (2011).
13. Nie, Y., Bergendahl, V., Hei, D. J., Jones, J. M., Palecek, S. P. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol. Prog. 25, 20-31 (2009).
14. Amit, M. , et al. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc. 6, 572-9 (2011).
15. Khetan, S. , et al. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat. Mater. 12, 458-65 (2013).
16. Zweigerdt, R., Olmer, R., Singh, H., Haverich, A., Martin, U. Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 6, 689-700 (2011).
17. Chen, V. C. , et al. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res. 8, 388-402 (2012).
18. Krawetz, R. , et al. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng. Part C. Methods 16, 573-82 (2010).
19. Murphy, W. L., McDevitt, T. C., Engler, A. J. Materials as stem cell regulators. Nat. Mater. 13, 547-557 (2014).
20. Lei, Y., Schaffer, D. V. A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc. Natl. Acad. Sci. USA 110, E5039-E5048 (2013).
21. Keung, A. J., Asuri, P., Kumar, S., Schaffer, D. V. Soft microenvironments promote the early neurogenic differentiation but not selfrenewal of human pluripotent stem cells. Integr. Biol. 4, 1049-1058 (2012).
22. Saha, K. , et al. Substrate modulus directs neural stem cell behavior. Biophys. J. 95, 4426-4438 (2008).
23. Chambers, S. M. , et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275-280 (2009).
24. Hughes, C. S., Postovit, L. M., Lajoie, G. A. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10, 1886-1890 (2010).
25. Hegarty, S. V., Sullivan, A. M., O'Keeffe, G. W. Midbrain dopaminergic neurons: A review of the molecular circuitry that regulates their development. Dev. Biol. 379, 123-138 (2013).
26. Arenas, E., Denham, M., Villaescusa, J. C. How to make a midbrain dopaminergic neuron. Development 142, 1918-1936 (2015).
27. Abeliovich, A., Hammond, R. Midbrain dopamine neuron differentiation: Factors and fates. Dev. Biol. 304, 447-454 (2007).
28. Ang, S.-L. Transcriptional control of midbrain dopaminergic neuron development. Development 133, 3499-506 (2006).
29. Georgala, P. A., Carr, C. B., Price, D. J. The role of Pax6 in forebrain development. Dev. Neurobiol. 71, 690-709 (2011).
30. Lan, F. , et al. Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells. Cell Stem Cell 12, 101-113 (2013).
31. Grace, A. A., Bunney, B. S. The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4, 2877-2890 (1984).
32. Grace, A. A., Bunney, B. S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10, 301-315 (1983).
33. Hartfield, E. M. , et al. Physiological characterisation of human iPS-derived dopaminergic neurons. PLoS One 9, e87388 (2014).
34. Huang, Y. L., Walker, A. S., Miller, E. W. A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing. J. Am. Chem. Soc. 137, 10767-10776 (2015).
35. Miller, E. W. , et al. Optically monitoring voltage in neurons by photo-induced electron transfer through molecular wires. Proc. Natl. Acad. Sci. USA 109, 2114-2119 (2012).
36. Bye, C. R., Jönsson, M. E., Björklund, A., Parish, C. L., Thompson, L. H. Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors. Proc. Natl. Acad. Sci. 112, E1946-E1955 (2015).
37. Maria, S. , et al. Improved cell therapy protocol for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC and non human primate iPSC-derived DA neurons. 31, 1548-1562 (2014).
38. Oh, S. , et al. Combined Nurr 1 and Foxa 2 roles in the therapy of Parkinson's disease. EMBO Mol. Med. 7, 1-17 (2015).
39. Steinbeck, J. a. , et al. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model. Nat. Biotechnol. 33, 204-209 (2015).
40. Liu, Q. , et al. Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation. Cytotherapy 15, 999-1010 (2013).
41. Sánchez-Danés, a., et al. Efficient Generation of A9 Midbrain Dopaminergic Neurons by Lentiviral Delivery of LMX1A in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Hum. Gene Ther. 23, 56-69 (2012).
42. Politis, M., et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2, 38-46 (2010).
43. Grealish, S., et al. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 133, 482-95 (2010).
44. Veenvliet, J. V. J., et al. Specification of dopaminergic subsets involves interplay of En1 and Pitx3. Development 140, 3373-84 (2013).
45. Grace, A. A., Bunney, B. S. In Psychopharmacology (eds Bloom, F. E., Kupfer, D. J. ) (Raven Press, 1995).
46. Chan, L. Y., Birch, W. R., Yim, E. K. F., Choo, A. B. H. Temporal application of topography to increase the rate of neural differentiation from human pluripotent stem cells. Biomaterials 34, 382-92 (2013).
47. Benoit, D., Schwartz, M., Durney, A., Anseth, K. Small molecule functional groups for the controlled differentiation of human mesenchymal stem cells encapsulated in poly (ethylene glycol) hydrogels. Nat. Mater. 7, 816-823 (2008).
48. Dupont, S., et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
49. Simon, H. H., Saueressig, H., Wurst, W., Goulding, M. D., O'Leary, D. D. M. Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes. J. Neurosci. 21, 3126-3134 (2001).
50. Kittappa, R., Chang, W. W., Awatramani, R. B., McKay, R. D. G. The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol. 5, e325 (2007).
51. Pristerà, A., et al. Transcription factors FOXA1 and FOXA2 maintain dopaminergic neuronal properties and control feeding behavior in adult mice. Proc. Natl. Acad. Sci. USA 112, E4929-4938 (2015).
52. Kirkeby, A., et al. Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease. Cell Stem Cell 1-14, doi: 10. 1016/j. stem. 2016. 09. 004 (2016).
53. Woodford, C. R., et al. Improved PeT molecules for optically sensing voltage in neurons. J. Am. Chem. Soc. 137, 1817-1824 (2015).